Florenzo Iannone

17.0k total citations · 1 hit paper
349 papers, 6.8k citations indexed

About

Florenzo Iannone is a scholar working on Rheumatology, Hematology and Ophthalmology. According to data from OpenAlex, Florenzo Iannone has authored 349 papers receiving a total of 6.8k indexed citations (citations by other indexed papers that have themselves been cited), including 213 papers in Rheumatology, 70 papers in Hematology and 62 papers in Ophthalmology. Recurrent topics in Florenzo Iannone's work include Rheumatoid Arthritis Research and Therapies (116 papers), Systemic Lupus Erythematosus Research (75 papers) and Autoimmune and Inflammatory Disorders Research (69 papers). Florenzo Iannone is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (116 papers), Systemic Lupus Erythematosus Research (75 papers) and Autoimmune and Inflammatory Disorders Research (69 papers). Florenzo Iannone collaborates with scholars based in Italy, Switzerland and France. Florenzo Iannone's co-authors include Giovanni Lapadula, Giuseppe Lopalco, Luca Cantarini, Antonio Vitale, Donato Rigante, Vincenzo Venerito, Mauro Galeazzi, Bruno Frediani, Giacomo Emmi and Claudia Fabiani and has published in prestigious journals such as SHILAP Revista de lepidopterología, Hepatology and International Journal of Molecular Sciences.

In The Last Decade

Florenzo Iannone

323 papers receiving 6.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

FRI0298 The Impact of DMARD Co-Therapy on Abatacept Effectiveness in Rheumatoid Arthritis Patients. A Pan-European Analysis of RA Registries

2014 285 citations Axel Finckh, Florenzo Iannone et al. Annals of the Rheumatic Diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Florenzo Iannone Italy	42	3.3k	1.4k	1.2k	1.1k	1.0k	349	6.8k
Mauro Galeazzi Italy	49	3.8k 1.1×	1.9k 1.3×	1.2k 1.1×	1.2k 1.1×	2.0k 1.9×	199	7.9k
G Triolo Italy	41	2.3k 0.7×	2.1k 1.5×	553 0.5×	1.3k 1.2×	1.1k 1.1×	209	5.7k
Giacomo Emmi Italy	42	1.8k 0.5×	926 0.7×	1.9k 1.7×	724 0.7×	1.1k 1.1×	196	5.1k
Yeong Wook Song South Korea	46	4.2k 1.3×	2.1k 1.5×	320 0.3×	1.0k 1.0×	1.6k 1.5×	309	8.3k
Yusuf Yazıcı United States	43	4.2k 1.3×	643 0.5×	1.2k 1.0×	1.5k 1.4×	576 0.6×	237	6.1k
Daniel Wendling France	49	5.4k 1.6×	2.4k 1.7×	295 0.3×	1.5k 1.4×	1.1k 1.0×	514	9.1k
Francesco Ciccia Italy	43	3.1k 0.9×	2.9k 2.0×	303 0.3×	1.7k 1.5×	1.8k 1.8×	232	7.1k
Giovanni Lapadula Italy	38	2.1k 0.6×	1.0k 0.7×	327 0.3×	628 0.6×	521 0.5×	191	4.5k
Amr H. Sawalha United States	52	2.6k 0.8×	2.9k 2.1×	394 0.3×	432 0.4×	2.0k 1.9×	158	6.8k
Bruno Frediani Italy	42	1.9k 0.6×	706 0.5×	1.2k 1.0×	635 0.6×	1.1k 1.0×	249	4.8k

Countries citing papers authored by Florenzo Iannone

Since Specialization

Citations

This map shows the geographic impact of Florenzo Iannone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Florenzo Iannone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Florenzo Iannone more than expected).

Fields of papers citing papers by Florenzo Iannone

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Florenzo Iannone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Florenzo Iannone. The network helps show where Florenzo Iannone may publish in the future.

Co-authorship network of co-authors of Florenzo Iannone

This figure shows the co-authorship network connecting the top 25 collaborators of Florenzo Iannone. A scholar is included among the top collaborators of Florenzo Iannone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Florenzo Iannone. Florenzo Iannone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Venerito, Vincenzo, Latika Gupta, Steven J. Mileto, Florenzo Iannone, & Emre Bılgın. (2025). Ethical challenges and regulatory pathways for artificial intelligence in rheumatology. Rheumatology Advances in Practice. 9(2). rkaf035–rkaf035.

Cacciapaglia, Fabio, et al.. (2024). Modulation of IL-6 receptor/STAT3 downstream signaling in rheumatoid arthritis patients. Experimental and Molecular Pathology. 141. 104951–104951. 3 indexed citations

Fornaro, Marco, et al.. (2024). Anti-SAE dermatomyositis: clinical and histologic characteristics from a monocentric Italian cohort. Clinical and Experimental Rheumatology. 42(2). 295–301.

Cacciapaglia, Fabio, et al.. (2024). Anti-aquaporin-5 and anti-poly-U-binding-factor-60kDa protein antibodies in primary Sjogren's disease patients: preliminary data and correlation with disease activity indices. Clinical and Experimental Rheumatology. 42(12). 2420–2426.

Praino, Emanuela, Antonia Abbinante, Gianfranco Favia, et al.. (2024). Orofacial Manifestation of Systemic Sclerosis: A Cross-Sectional Study and Future Prospects of Oral Capillaroscopy. Diagnostics. 14(4). 437–437. 2 indexed citations

Manfredi, Andreina, Vincenzo Venerito, Massimiliano Cazzato, et al.. (2024). Pulmonary Progressive Fibrosis in Rheumatoid Arthritis and Primary Sjogren Syndrome: Similarities and Differences. Journal of Clinical Medicine. 13(21). 6508–6508.

Lopalco, Giuseppe, et al.. (2024). The management of axial spondyloarthritis with cutting-edge therapies: advancements and innovations. Expert Opinion on Biological Therapy. 24(8). 835–853.

Venerito, Vincenzo, Andreina Manfredi, Antonio Carletto, et al.. (2023). Evolution of Rheumatoid-Arthritis-Associated Interstitial Lung Disease in Patients Treated with JAK Inhibitors: A Retrospective Exploratory Study. Journal of Clinical Medicine. 12(3). 957–957. 18 indexed citations

Hetland, Merete Lund, Axel Finckh, Jacques‐Eric Gottenberg, et al.. (2023). Safety outcomes in patients with rheumatoid arthritis treated with abatacept: results from a multinational surveillance study across seven European registries. Arthritis Research & Therapy. 25(1). 101–101. 3 indexed citations

10.

Floris, Alberto, Gerard Espinosa, Giuseppe Lopalco, et al.. (2023). Organ damage is a major determinant of work productivity impairment in Behçet’s syndrome: a post hoc analysis of the BODI validation study. Lara D. Veeken. 64(2). 810–814. 1 indexed citations

11.

Vitale, Antonio, Stefano Alivernini, Roberto Caporali, et al.. (2023). From Bench to Bedside in Rheumatoid Arthritis from the “2022 GISEA International Symposium”. Journal of Clinical Medicine. 12(2). 527–527. 1 indexed citations

12.

Spinelli, Francesca Romana, Fabrizio Conti, Roberto Caporali, Florenzo Iannone, & Fabio Cacciapaglia. (2023). Janus kinase inhibitors: between prescription authorization and reimbursability. SHILAP Revista de lepidopterología. 75(4). 1 indexed citations

13.

Courvoisier, Delphine S., Kim Lauper, Joanna Kedra, et al.. (2022). EULAR points to consider when analysing and reporting comparative effectiveness research using observational data in rheumatology. Annals of the Rheumatic Diseases. 81(6). 780–785. 12 indexed citations

14.

Ceccarelli, Fulvia, Marcello Govoni, Matteo Piga, et al.. (2022). Arthritis in Systemic Lupus Erythematosus: From 2022 International GISEA/OEG Symposium. Journal of Clinical Medicine. 11(20). 6016–6016. 15 indexed citations

15.

Cacciapaglia, Fabio, Paolo Airó, Marco Fornaro, et al.. (2022). Survival and prognostic factors from a multicentre large cohort of unselected Italian systemic sclerosis patients. Lara D. Veeken. 62(4). 1552–1558. 6 indexed citations

16.

Giuggioli, Dilia, Cosimo Bruni, Fabio Cacciapaglia, et al.. (2021). Pulmonary arterial hypertension: guidelines and unmet clinical needs. SHILAP Revista de lepidopterología. 72(4). 228–246. 9 indexed citations

17.

Fabiani, Claudia, Jurgen Sota, Maite Sáinz de la Maza, et al.. (2020). New Potential Weapons for Refractory Scleritis in the Era of Targeted Therapy. Mediators of Inflammation. 2020. 1–6. 20 indexed citations

18.

Venerito, Vincenzo, et al.. (2019). Paradoxical Pustular Psoriasis in a Patient With Psoriatic Arthritis on Secukinumab Treatment. JCR Journal of Clinical Rheumatology. 26(6). e208–e209. 12 indexed citations

19.

Vitale, Antonio, Ida Orlando, Giuseppe Lopalco, et al.. (2017). Demographic, clinical and therapeutic findings in a monocentric cohort of adult patients with suspected PFAPA syndrome.. PubMed. 34(6 Suppl 102). 77–81. 18 indexed citations

20.

Iannone, Florenzo, Marilina Tampoia, Margherita Giannini, et al.. (2016). Changes in anti-cyclic citrullinated peptide antibodies and rheumatoid factor isotypes serum levels in patients with rheumatoid arthritis following treatment with different biological drugs.. PubMed. 34(3). 424–9. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact